Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

Nebraska Oncology Society
E

2020 ASCO Update on RET-Altered Thyroid Cancer: What Is the Efficacy of New RET Inhibitors? Should We Use Them 1L or 2L?

By Nebraska Oncology Society FEATURING Eric Sherman
By Nebraska Oncology Society FEATURING Eric Sherman
30 views
January 5, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

20:14
Exelixis

Hypothetical Patient Case: RAI-R Metastatic Differentiated Thyroid C…

Feat. R. Alter, R. Shameem

Featured Video

09:50
Incyte

Managing Chronic GVHD Master Class Series: Best Practices at 100 Day…

Feat. C. Cutler
Head and Neck
08:09

ESMO 2023 Insights: "AIM-HN Study Evaluating Tipifarnib in mHRAS, Re…

Insights from 2023 ESMO Annual Meeting

A. Ho

120 views
18:07

NOS ASCO® 2023 Review: Nasopharynx Cancer

Nebraska Oncology Society

E. Sherman

1.8K views
22:27

NOS ASCO® 2023 Review: Head & Neck Cancer De-Escalation

Nebraska Oncology Society

E. Sherman

243 views
47:18

ASCO 2022 Review of Head & Neck Cancer Updates

Nebraska Oncology Society

E. Sherman

542 views
09:41

ASCO 2020 Review of Transoral Robotic Surgery for OPC : Is 2-yr PFS …

Nebraska Oncology Society

E. Sherman

17 views
09:24

2020 ASCO LA-HNSCC Trials Review: What Is the Efficacy of Weekly CDD…

Nebraska Oncology Society

E. Sherman

18 views
11:38

ASCO 2020 Update on DO-IMRT & HNC Metastatic: Does Change in IMRT Le…

Nebraska Oncology Society

E. Sherman

26 views
04:56

2020 ASCO Update on Metastatic/Recurrent HNSCC: What Is the Efficacy…

Nebraska Oncology Society

E. Sherman

22 views
08:09

2020 ASCO Update on RET-Altered Thyroid Cancer: What Is the Efficacy…

Nebraska Oncology Society

E. Sherman

30 views